Efficacy and quality of life after transobturator tension-free vaginal tape procedure for female stress urinary incontinence.
Background: Nowadays, tension-free transobturator midurethral sling procedures have been gaining popularity in the surgical management of female stress urinary incontinence (SUI). However, quality of life (QoL) assessment following this new procedure is sparingly reported and requires further investigations for credentialing this intervention as a standard of care for women with SUI.
Objective: To evaluate the QoL outcome using King's Health Questionnaires (KHQ) scale following tension-free transobturator tape procedure.
Materials and Methods: We evaluated 31 women with genuine SUI in a tertiary medical teaching hospital for QoL before and after the surgery using KHQ. The responses were analyzed for internal consistency, criterion validity, and improvements in various domains in relation to QoL, which could have been affected by their urinary symptoms.
Results: Cronbach's [alpha] statistics indicated good correlation between various items of the KHQ scale before and after surgery (0.88 vs 0.81). The criterion validity of the scale against Sandvik Short Format (SSF) indicated a good agreement between these two scales before intervention and during follow-up (Spearman's rank correlation coefficient: 0.872 vs. 0.638). When it came to various domains of KHQ scale, there were significant improvements in all items (p < 0.0001) except General Health Perception (p = 0.69). There was no procedure-related morbidity.
Conclusion: The results of this study indicate that KHQ can be effectively used for assessing QoL after TOT procedures. This procedure is also safe and effective for continence treatment.
KEY WORDS: Quality of life, King's Health Questionnaire, Tension-free transobturator tape (TOT)
The International Continence Society (ICS) defines stress urinary incontinence (SUI) as the involuntary leakage of urine during increased abdominal pressure (e.g., during sneezing, coughing, walking, and sudden change of posture) in the absence of detrusor contraction.  Though SUI is said to affect 4%-35% of adult women,  the exact incidence in the Indian context is not known because of lack of epidemiological studies.  There are several social issues associated with involuntary urinary leakage such as anxiety and distress in public places, personal issues such as loss of self-esteem, marital disharmony, shame, discomfort, in addition to cultural and religious implications.  Though the condition does not endanger one's life, the affected women give up many aspects of their lifestyle, retire from social interactions, and develop pessimistic attitude. In the USA alone, over $12 billion are spent annually for both nonsurgical and surgical management of SUI, indicating the financial burden associated with involuntary leakage of urine. 
In the initial phase, nonsurgical therapies such as bladder training, pelvic floor exercises, and drug therapy may be beneficial; surgery is the main stay of treatment in long-term treatment. Currently, more than 200 surgical procedures have been described  and of late, tension-free transobturator tape (TOT) repair is gaining wide expectance because it is associated with minimal hospital stay and the procedure can be done under local anesthesia without the risk of bladder injury.
Normally, the success of any surgical intervention is measured by urodynamic studies of lower urinary tract that assess the bladder storage and emptying capacity. The methods of clinical assessment such as pad test, stress test, and Q-tip test are grossly inadequate in diagnosis and follow-up of SUI.  Sophisticated gadgets are required to study intravesical and urethral pressures during periods of raised inra-abdominal pressure, but still there may be significant differences with regard to subjective (what the patient feels) and objective (what the operative surgeon thinks as a cure) improvement regarding quality of life (QoL) following surgery. 
There are several varieties of questionnaires regarding QoL in urinary incontinence and the number is constantly increasing over the years.  Among these questionnaires, King's Health Questionnaire (KHQ) is the most reputed and has been translated into more than 45 languages.  Several reports on medical and surgical interventions in urinary incontinence have liberally used KHQ system of QoL assessment not only to show improvement in the condition before and after the procedure, but also the persistence and continuation of therapeutic benefits during short-term and longterm surveillances.  Other advantages include the short time required to administer and complete the questionnaires (on average 5 min), age and gender appropriateness (valid for both male and females between 17 and 85 years), coverage of various bladder conditions (stress incontinence, urge incontinence, mixed incontinence, over active bladder), and zero cost to the participant. The aim of this study was to evaluate the QoL outcome using KHQ scale following TOT procedure.
Materials and Methods
We evaluated 31 women with SUI who underwent TOT repair in our hospital from August 2013 to June 2014. Before the surgery, all the patients were urodynamically assessed to rule out other types of incontinence. Clinical examination was carried out to show urinary leak on coughing and Valsalva maneuver. All the patients had ultrasound examination to note the postvoid residual urine. Patients with isolated urge incontinence were excluded. Other exclusion criteria included presence of neurological disorders affecting the urinary function, active urinary tract infection, and significant uterovaginal prolapse requiring different surgical approach. Patients who were put on anticholinergic medications to control the urinary urgency were also excluded. The hospital regulatory body gave the necessary clearance to conduct the study.
Sample size estimation
Dedicacao and co-workers  compared the QoL in different types of urinary incontinence before the surgery. They reported that the mean score for item General Health Perception was 47.58[+ or -]19.74 for SUI before surgery. The inventor of KHQ scale has suggested that a change by 10 points in the mean score signifies a medium effect.  We calculated the desired sample size based on these assumptions so that we could achieve 80% power and 0.05 significance level by using the following formula:
where z[alpha] = 1.96 (critical value that divides the central 95% of z distribution from 5% in the tails),
z[beta] = 0.84 (critical value that separates the lower 20% of distribution from upper 80%),
[sigma] = standard deviation, [DELTA][mu] = required difference in mean for significant difference.
Accordingly, the proposed surgical intervention required recruitment of 31 cases to show significant improvement in KHQ scale as a result of surgery.
The KHQs were administered at the beginning of the procedure and during the postoperative follow-up period (at the end of 3 months). The questionnaires included three parts consisting of 21 items (Annexure 1). Part 1 contained general health perception and incontinence impact (one item each). Part 2 contained role limitations, physical limitations, social limitations (two items each), personal relationships, emotions (three items each) and sleep/energy (two items), and severity measures (four items). Part 3 was considered as a single item and contained 10 responses in relation to frequency, nocturia, urgency, urge, stress, intercourse incontinence, nocturnal enuresis, infections, pain, and difficulty in voiding. The responses in KHQ were scored as four-point rating system. The eight subscales ("domains") were scored between 0 (best) and 100 (worst). The Symptom Severity Scale was scored from 0 (best) to 30 (worst). Decreases in KHQ domain scores indicated an improvement in QoL. The minimally important difference--the smallest change in score that subjects perceived as beneficial--was three points for the Symptom Severity Scale and five points for all other KHQ domains. Twice of these values indicate medium change and thrice large change.  The lower scores indicated patient wellbeing and higher scores meant that the person was severely affected by the disease condition.
The main surgical procedure (TOT procedure) involved placing a synthetic sling to support the midurethra, which itself was supported laterally through obturator membrane (refer to operative Figures 1-20). The procedure was performed under general or regional anesthesia. The patient was placed in dorsal lithotomy position with thighs flexed at 120[degrees] angle. A small (1 cm) incision was made suburethrally in the anterior vaginal wall at midurethral level and the dissection was carried out to the pubic arch on either side toward anterior obturator notch in the obturator foramen. A tunnel was created around this path and then a mesh was passed through it using a helical introducer and brought out through two small (1 cm) skin incisions on either side of the groin below the insertion of adductor longus tendon. Once the tape was in place, it was adjusted to the appropriate tension, then the excess mesh was trimmed and surgical incisions were closed with suture.
Data were analyzed using SPSS, version 16, for Windows (SPSS Inc., Chicago, IL, USA). Descriptive analysis was performed to obtain mean, standard deviation, and median values for various domains in KHQ QoL assessment. To decide whether the therapeutic intervention for SUI resulted in significant benefit after the procedure, mean and standard deviations of the scores before after the treatment were analyzed by Wilcoxon signed-rank test. A p-value of 0.05 or less was considered statistically significant. Internal consistency was measured with Cronbach's [alpha]. An [alpha] value of [greater than or equal to]0.7 was considered as acceptable. The criterion validity was tested by correlating total scores of KHQ with Sandvik two-item scale.  Spearman's rank correlation coefficient was used to test the agreement between these two systems of QoL assessment.
The demographic details of the patients are shown in Table 1. Many of the patients were postmenopausal and had isolated SUI and hence did not require concurrent cystocele repair. Keeping in mind the cost of synthetic vaginal tape exclusively meant for transvaginal repair, we used routine proline mesh used for incisional hernia repair and tailored it to suit our requirement. Though the repair could be carried out under local anesthesia, we resorted to regional or general anesthesia keeping patient's comfort in mind. Initially, during the learning curve, we required roughly 45-60 min. However toward the end, the entire procedure could be completed within 30 min. The mean[+ or -]SD operative time was 43[+ or -]18 min. No significant blood loss was encountered during surgery or afterwards. Routine cystoscopy was not recommended for TOT procedure, as the chances of bladder injury are remote. However, we did check bladder integrity cystoscopically, and none of our patients had vesical injury. Patients were discharged the next day. The follow-up period ranged from 2 to 48 months. The KHQ QoL assessment results were noted before surgery and 3 months after the surgery.
Reliability analysis of KHQ scale was carried out to find the internal consistency of the questionnaires both before the surgery and during follow-up. Table 2 shows reliability statistics for internal consistency. Cronbach's [alpha] statistics was used to calculate correlations between items. An [alpha] value of [greater than or equal to] 0.7 was considered acceptable (interpretation for Cronbach's [alpha] statistics; >0.9 [right arrow] excellent, 0.8-0.9 [right arrow] good, 0.7-0.8 [right arrow] acceptable, 0.6-0.7 [right arrow] questionable, 0.5-0.6 [right arrow] poor). From Table 2, it can be inferred that the KHQ QoL assessment has highly acceptable [alpha] values, proving it to be one of the important tools to assess urinary incontinence in women.
To assess the criterion validity of KHQ QoL tool, its correlation with Sandvik Short Form (SSF) questionnaire was analyzed. Sandvik format is one of the shortest urinary continence questionnaires available and can be easily administered and used to test the validity of long-form questionnaires. It has only two items, the first question refers to experiencing urinary leakage (less than once month, 1; many times in a month, 2; many times in a week, 3; every day and night, 4) and the second question refers to amount of urinary leakage (drops, 1; significant loss, 2). The Sandvik severity index is obtained by multiplying the results of questions (1) and (2). The symptoms are considered mild when the score is 1-2, moderate for score 3-4, and severe when the score is 6-8.
Patient satisfaction was measured by analyzing various domains of KHQ scale (Table 4; Figure 21). As said earlier, drop in scores following surgery indicated improvement in that particular domain. All the domains showed significant improvement (<0.0001) in QoL except general health perception. However, this finding was not statistically significant (p = 0.69).
In general, the extent of change in KHQ score was significantly large and indicated improvement in patient outlook toward herself and her environment. The median improvement in physical limitations and severity measures were above 50 points, incontinence impact and role limitations above 40, and emotions above 30. There was a significant improvement of 10 points in symptom severity scale too, considering the fact that it is a 30-point scale, whereas others are 100-point scales.
There were no complications such as vaginal hematoma, bladder perforation, and tape infection in the present series. One patient had slight voiding difficulty in the first week; however, she did not require catheterization. All the patients had significant improvement in their urinary diary.
From the last century, more than 200 surgical procedures have been invented for the management of female SUI.  Women were offered various operations, for example, suburethral (Kelly) plication, Stamey retropubic needle urethropexy, open or laparoscopic Burch colposuspension, and Aldridge fascial suburethral sling procedure. Since the year 2000, literally all of these operations have been replaced in urogynecological practice by transvaginal retropubic or TOT midurethral synthetic slings as these procedures can be done on day-care basis, have lesser chance of bladder injury, take shorter recovery time, and cause less postoperative voiding dysfunction.
It was Nickel in 1998, a veterinary surgeon from Department of Clinical Sciences of Companion Animals, University of Utrecht, the Netherlands, who successfully performed sling procedure in female dogs by passing a synthetic ribbon on either side of urethra through obturator foramen.  The human implantation of midurethral tape was introduced in France in 2001 by Delorme, who used nonwoven polypropylene tape coated with silicon, which was suspended laterally through obturator fascia.  Since then, thousands of these procedures have been performed worldwide.
Traditionally, measurement of impact of any surgical intervention to cure female SUI requires good documentation and record-keeping of bladder diary, objective clinical indicators such as urinary leak after raised intra-abdominal pressure, and urodynamic findings. But what is seen as an improvement by the surgeon may not actually reflect on patient satisfaction. There are several other aspects of human psychology and sexuality beyond the surgical cure, hence ICS strongly insists on standardization of the outcome measures with respect to QoL in clinical trials involving urinary incontinence. 
The need for QoL assessment was felt by the scientific community long ago, and this led to invention of various assessment tools, for example, Urogenital Distress Inventory in 1994,  Bristol Female Lower Urinary Tract Symptoms (B-FLUTS) questionnaire in 1996,  Urinary Incontinence Quality of Life (I-Qol) instrument in 1996,  KHQ in 1997,  and Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (PISQ) in 2001, . Among these questionnaires, KHQ still enjoys wide popularity and has been extensively referenced in most of the studies (more than 500 publications indexed in PubMed database) involving assessment of improvement in urinary symptoms following either medical or surgical therapy.
Although this study focuses on the use of KHQ for assessment of genuine SUI, several researchers have opined that this tool can be used even for women with other forms of urinary difficulties such as overactive bladder and mixed urinary incontinence.
Tamanini et al.  from Brazil were one of the few researchers who evaluated concurrent validity, internal consistency, and responsiveness of KHQs before and after stress urinary incontinence surgery. They studied 68 patients who underwent pubovaginal synthetic mesh repair and were administered KHQ before and after the procedure. They checked the validity of this tool by comparing the scores of KHQ with Stamey incontinence grading. They observed significant improvement in various domains of KHQ following the surgery and also found a good correlation between KHQ and Stamey incontinence grading. We too observed similar findings, and we compared results of KHQ with SSF questionnaires and found good statistical correlations between the two tools.
In another study from Poland, the psychometric property of KHQ was cross-validated with the World Health Organization Quality of Life (WHOQOL-BREF) questionnaires.  It was found that there was significant correlation between two of these urinary severity scales. Juul et al.  from Department of Gynaecology, Tygerberg Hospital, Western Cape, South Africa, conducted validation study of KHQ in local South African English, Afrikaans, and isiXhosa women with urinary incontinence. The questionnaires were administered in all the three local languages and validated for all the domains in KHQ. The tool performed equally well in all three language versions and the authors were of the opinion that KHQ can be used both in clinical practice and research involving different ethnicity, religion, and communities.
Frohme et al.  from a university hospital from Germany conducted QoL outcome in 116 women who underwent TOT procedure using Monarc Subfascial Hammock ( American Medical System, USA). They compared subjective and objective improvements in QoL using KHQ and ICIQ-SF (International Consultation on Incontinence Questionnaire--Short Form). They categorized these patients into three groups (normal weight, n = 31; overweight, n = 56; and obese, n = 29), and their results indicated that there were no significant differences between these groups in terms of success, QoL scores, and postoperative complications. There was one case of postoperative bleeding, and temporary voiding difficulty was experienced by six women. The mean operation time was 40 min. The KHQ scale showed continual improvements in all domains irrespective of initial body mass index (BMI). The overall cure rate was 93% at the end of 3 years of follow-up. They opined that TOT is a safe procedure for urinary incontinence in women of all weight ranges, and the outcome measures can be easily assessed by KHQ system of scoring the severity of urinary incontinence. The results of our study are in strong agreement with their findings. However, we did not compare outcome measures according to BMI as very few of our patients were having BMI above 25 kg/[m.sup.2].
Our results indicate that KHQ can be effectively used for assessing QoL after surgical treatment. The tool is available online for use and may be incorporated in all scientific researches involving urinary incontinence procedures, not only conservative, but also interventional; the benefit of these interventions can be measured from the patient's perspective.
[1.] Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003;61(1):37-49.
[2.] Thom D. Variation in estimates of urinary incontinence prevalence in the community: effects of differences in definition, population characteristics, and study type. J Am Geriatr Soc 1998;46(4):473-80.
[3.] Singh U, Agarwal P, Verma ML, Dalela D, Singh N, Shankhwar P. Prevalence and risk factors of urinary incontinence in Indian women: a hospital-based survey. Indian J Urol 2013; 29(1):31-6.
[4.] Fultz H, Burgio K, Diokno AC, Kinchen KH, Obenchain R, Bump RC. Burden of stress urinary incontinence for community-dwelling women. Am J Obstet Gynecol 2003; 189:1275-82.
[5.] Chong EC, Khan AA, Anger JT. The financial burden of stress urinary incontinence among women in the United States. Curr Urol Rep 2011;12(5):358-62.
[6.] Rovner ES, Wein AJ. Treatment options for stress urinary incontinence. Rev Urol 2004;6(Suppl 3):S29-47.
[7.] De Tayrac R, Letouzey V, Triopon G, Wagner L, Costa P. [Clinical diagnosis and evaluation of female urinary incontinence]. J Gynecol Obstet Biol Reprod (Paris) 2009;38(Suppl 8):S153-65.
[8.] Stach-lempinen B, Kirkinen P, Laippala P, Metsanoja R, Kujansuu E. Do objective urodynamic or clinical findings determine impact of urinary incontinence or its treatment on quality of life? Urology 2004;63(1):67-71.
[9.] Bonniaud V, Raibaut P, Guyatt G, Amarenco G, Parratte B. [Symptom and quality of life assessment in urinary disorders]. Ann Readapt Med Phys 2005;48(6):392-403.
[10.] Reese PR, Pleil AM, Okano GJ, Kelleher CJ. Multinational study of reliability and validity of the King's Health Questionnaire in patients with overactive bladder. Qual Life Res 2003; 12(4):427-42.
[11.] Avery KN, Bosch JL, Gotoh M, Naughton M, Jackson S, Radley SC et al. Questionnaires to assess urinary and anal incontinence: review and recommendations. J Urol 2007;177(1):39-49.
[12.] Dedicacao AC, Haddad M, Saldanha MES, Driusso P. Comparison of quality of life for different types of female urinary incontinence. Rev Bras Fisioter 2009;13:116-22.
[13.] Kelleher CJ, Pleil AM, Reese PR, Burgess SM, Brodish PH. How much is enough and who says so? BJOG 2004;111(6):605-12.
[14.] Sandvik H, Hunskaar S, Seim A, Hermstad R, Vanvik A, Bratt H. Validation of a severity index in female urinary incontinence and its implementation in an epidemiological survey. J Epidemiol Community Health 1993;47(6):497-9.
[15.] Nickel RF, Wiegand U, Van den Brom WE. Evaluation of a transpelvic sling procedure with and without colposuspension for treatment of female dogs with refractory urethral sphincter mechanism incompetence. Vet Surg 1998;27(2):94-104.
[16.] Delorme E. [Transobturator urethral suspension: mini-invasive procedure in the treatment of stress urinary incontinence in women]. Prog Urol 2001;11(6):1306-13.
[17.] Haylen BT, De Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 2010;29(1):4-20.
[18.] Shumaker SA, Wyman JF, Uebersax JS, McClish D, Fantl JA. Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group. Qual Life Res 1994;3:291-306.
[19.] Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P. The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing. Br J Urol 1996;77:805-12.
[20.] Wagner TH, Patrick DL, Bavendam TG, Martin ML, Buesching DP. Quality of life of persons with urinary incontinence: development of a new measure. Urology 1996;47:67-71.
[21.] Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 1997;104(12):1374-9.
[22.] Rogers RG, Kammerer-Doak D, Villarreal A, Coates K, Qualls C. A new instrument to measure sexual function in women with urinary incontinence or pelvic organ prolapse. Am J Obstet Gynecol 2001;184:552-8.
[23.] Tamanini JT, Dambros M, D'Ancona CA, Palma PC, Botega NJ, Rios LA et al. Concurrent validity, internal consistence and responsiveness of the Portuguese version of the King's Health Questionnaire (KHQ) in women after stress urinary incontinence surgery. Int Braz J Urol 2004;30(6):479-86.
[24.] Kulesza-Bronczyk B, Dobrzycka B, Gawrychowska J, Terlikowski R, Terlikowski SJ. Quality of life of urinary incontinent women. Prog Health Sci 2013;3(2):87-92.
[25.] Juul L, van Rensburg JA, Steyn PS. Validation of the King's Health Questionnaire for South Africa in English, Afrikaans and isiXhosa. S Afr J OG 2012;18(3):82-4.
[26.] Frohme C, Ludt F, Varga Z, Olbert PJ, Hofmann R, Hegele A. TOT approach in stress urinary incontinence (SUI)--outcome in obese female. BMC Urol 2014;14:20.
Harshita Pandey (1), Shripad Hebbar (1), Arun Chawla (2)
(1) Department of Obstetrics and Gynaecology, Kasturba Medical College and Hospital, Manipal, Karnataka, India.
(2) Department of Urology, Kasturba Medical College and Hospital, Manipal, Karnataka, India.
Correspondence to: Shripad Hebbar, E-mail: firstname.lastname@example.org
Received February 3, 2015. Accepted February 7, 2015
Access this article online
Quick Response Code:
How to cite this article: Pandey H, Hebbar S, Chawla A. Efficacy and quality of life after transobturator tension-free vaginal tape procedure for female stress urinary incontinence. Int J Med Sci Public Health 2015;4:916-926
Source of Support: Nil, Conflict of Interest: None declared.
International Journal of Medical Science and Public Health Online 2015. [c] 2015 Shripad Hebbar. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for any purpose, even commercially, provided the original work is properly cited and states its license.
Table 1: Patient characteristics Parameter Mean (range)/n (%) Age (years) 57 (42-76) Parity 3.2 (1-5) BMI 24.2 (22-27) Postmenopausal 19 (61.3) Table 2: Reliability statistics for internal consistency Before surgery After surgery Items Mean SD Cronbach's Mean SD Cronbach's [alpha] [alpha] General 51.61 20.35 0.88 53.23 22.12 0.81 health perception Incontinence 66.13 17.3 29.81 17.78 impact Role limitations 54.1 14.79 12.48 11.34 Physical 66.81 19.02 16.19 12.42 limitations Social 33.35 25.95 17.03 15.77 limitations Personal 12.06 15.91 12.06 0 relationships Emotions 52.19 17.36 15.97 9.35 Sleep/Energy 24.74 13.35 11.42 12.49 Severity measures 67.29 11.36 16.29 5.31 Symptom severity 19.26 1.32 9.32 1.66 scale Table 3: KHQ vs. Sandvik QoL assessment correlation statistics Assessment Spearman's rank p-Value correlation coefficient Before surgery 0.872 <0.0001 After surgery 0.638 <0.0001 Table 4: Descriptive statistics of various domains of King's Health Questionnaire Before surgery After surgery General health perception Mean[+ or -]SD 51.6 [+ or -] 20.3 53.3 [+ or -] 22.1 Median 52 54 Incontinence impact Mean[+ or -]SD 66.1 [+ or -] 17.3 29.8 [+ or -] 17.8 Median 67 26 Role limitations Mean[+ or -]SD 54.1 [+ or -] 14.8 12.5 [+ or -] 11.3 Median 54 12 Physical limitations Mean[+ or -]SD 66.8 [+ or -] 19 16.2 [+ or -] 12.4 Median 67 16 Social limitations Mean[+ or -]SD 33.4 [+ or -] 26 17 [+ or -] 15.8 Median 33 17 Personal relationships Mean[+ or -]SD 12.1 [+ or -] 15.9 0 Median 12 0 Emotions Mean[+ or -]SD 52.2 [+ or -] 17.4 16 [+ or -] 9.4 Median 52 16 Sleep/Energy Mean[+ or -]SD 24.7 [+ or -] 13.4 11.4 [+ or -] 12.5 Median 24 11 Severity measures Mean[+ or -]SD 67.3 [+ or -] 11.4 16.3 [+ or -] 5.3 Median 67 16 Symptom severity scale Mean[+ or -]SD 19.3 [+ or -] 1.3 9.3 [+ or -] 1.7 Median 19 10 Change in points p-Value General health perception Mean[+ or -]SD 1.7 0.69 Median 2 Incontinence impact Mean[+ or -]SD 36.3 <0.0001 Median 41 Role limitations Mean[+ or -]SD 41.6 <0.0001 Median 42 Physical limitations Mean[+ or -]SD 50.6 <0.0001 Median 51 Social limitations Mean[+ or -]SD 16.4 <0.0001 Median 16 Personal relationships Mean[+ or -]SD 12.1 <0.0001 Median 12 Emotions Mean[+ or -]SD 36.2 <0.0001 Median 36 Sleep/Energy Mean[+ or -]SD 13.3 <0.0001 Median 13 Severity measures Mean[+ or -]SD 51 <0.0001 Median 51 Symptom severity scale Mean[+ or -]SD 10 <0.0001 Median 9 Figure 21: Patient satisfaction in various domains before and after surgery. Before Surgery After Surgery 1. General Health Perception 51.61 53.23 2. Incontinence Impact 66.13 29.81 3. Role Limitations 54.1 12.48 4. Physical Limitations 66.81 16.19 5. Social Limitations 33.35 17.03 6. Personal Relationships 12.06 12.06 7. Emitions 52.19 15.97 8. Sleep/Energy 24.74 11.42 9. Severity Measures 67.29 16.29 10. Symptom Severity Scale 19.26 9.32 Note: Table made from bar graph. ANNEXURE 1 BRITISH SOCIETY OF UROGYNAECOLOGY King's Health Questionnaires (KHQ) Q1. GENERAL HEALTH PERCEPTION: How would you describe your health at present? * Very good Q2. INCONTINENCE IMPACT: How much do you think your bladder problem affects your life? * Not at all Q3. ROLE: LIMITATIONS: Don your bladder problem affect A. your house hold tasks e.g. cleaning, * Not at all shopping etc? B. your job or normal daily actis ities outside * Not at all the home? Q4. PHYSICAL LIMITATIONS: Docs sour Madder problem affect A. your physical activities (e.g., going for walk. * Not at all run. sports, gym. etc.)? B. your affect travel? * Not at all Q5. SOCIAL LIMITATIONS: Does your Madder problem limit A. your social life? * Not at all B. your limit your ability to see/visit friends? * Not at all Q6. PERSONAL RELATIONSHIPS: Does your bladder problem affect A. your relationship with your partner? * Not at all B. your sex life? * Not at all C. your family life? * Not at all Q7. EMOTIONS: Does your Madder problem make A. you feel depressed? * Not at all B. you feel anxious and nervous? * Not at all C. you feel bad about yourself? * Not at all Q8. SLEEP/ ENERGY : Does your Madder problem A. affect your sleep? * Not at all B. make you feel worn out and tired? * Not at all Q9. SEVERITY MEASURES: A: Wear pads to keep dry? * Never B: Be careful how much fluid you drink? * Never C: Change your underclothes because they get wet * Never D: Worry in case you smell * Never Q10. SYMPTOM SEVERITY SCALE A. Frequency of urination * None B. Nocturia * None C. Urgency * None D. Urge Incontinence * None E. Stress Incontinence * None F. Nocturnal Enuresis * None G. Intercourse Incontinence * None H. Waterworks infection * None I. Bladder pain * None J. Postvoid dribble * None Q1. GENERAL HEALTH PERCEPTION: How would you describe your health at present? * Good Q2. INCONTINENCE IMPACT: How much do you think your bladder problem affects your life? * A little Q3. ROLE: LIMITATIONS: Don your bladder problem affect A. your house hold tasks e.g. cleaning, * A little shopping etc? B. your job or normal daily actis ities outside * A little the home? Q4. PHYSICAL LIMITATIONS: Docs sour Madder problem affect A. your physical activities (e.g., going for walk. * A little run. sports, gym. etc.)? B. your affect travel? * A little Q5. SOCIAL LIMITATIONS: Does your Madder problem limit A. your social life? * A little B. your limit your ability to see/visit friends? * A little Q6. PERSONAL RELATIONSHIPS: Does your bladder problem affect A. your relationship with your partner? * A little B. your sex life? * A little C. your family life? * A little Q7. EMOTIONS: Does your Madder problem make A. you feel depressed? * A little B. you feel anxious and nervous? * A little C. you feel bad about yourself? * A little Q8. SLEEP/ ENERGY : Does your Madder problem A. affect your sleep? * A little B. make you feel worn out and tired? * A little Q9. SEVERITY MEASURES: A: Wear pads to keep dry? * Sometimes B: Be careful how much fluid you drink? * Sometimes C: Change your underclothes because they get wet * Sometimes D: Worry in case you smell * Sometimes Q10. SYMPTOM SEVERITY SCALE A. Frequency of urination * Mild B. Nocturia * Mild C. Urgency * Mild D. Urge Incontinence * Mild E. Stress Incontinence * Mild F. Nocturnal Enuresis * Mild G. Intercourse Incontinence * Mild H. Waterworks infection * Mild I. Bladder pain * Mild J. Postvoid dribble * Mild Q1. GENERAL HEALTH PERCEPTION: How would you describe your health at present? * Fair Q2. INCONTINENCE IMPACT: How much do you think your bladder problem affects your life? * Moderately Q3. ROLE: LIMITATIONS: Don your bladder problem affect A. your house hold tasks e.g. cleaning, * Moderately shopping etc? B. your job or normal daily actis ities outside * Moderately the home? Q4. PHYSICAL LIMITATIONS: Docs sour Madder problem affect A. your physical activities (e.g., going for walk. * Moderately run. sports, gym. etc.)? B. your affect travel? * Moderately Q5. SOCIAL LIMITATIONS: Does your Madder problem limit A. your social life? * Moderately B. your limit your ability to see/visit friends? * Moderately Q6. PERSONAL RELATIONSHIPS: Does your bladder problem affect A. your relationship with your partner? * Moderately B. your sex life? * Moderately C. your family life? * Moderately Q7. EMOTIONS: Does your Madder problem make A. you feel depressed? * Moderately B. you feel anxious and nervous? * Moderately C. you feel bad about yourself? * Moderately Q8. SLEEP/ ENERGY : Does your Madder problem A. affect your sleep? * Moderately B. make you feel worn out and tired? * Moderately Q9. SEVERITY MEASURES: A: Wear pads to keep dry? * Often B: Be careful how much fluid you drink? * Often C: Change your underclothes because they get wet * Often D: Worry in case you smell * Often Q10. SYMPTOM SEVERITY SCALE A. Frequency of urination * Moderate B. Nocturia * Moderate C. Urgency * Moderate D. Urge Incontinence * Moderate E. Stress Incontinence * Moderate F. Nocturnal Enuresis * Moderate G. Intercourse Incontinence * Moderate H. Waterworks infection * Moderate I. Bladder pain * Moderate J. Postvoid dribble * Moderate Q1. GENERAL HEALTH PERCEPTION: How would you describe your health at present? * Poor Q2. INCONTINENCE IMPACT: How much do you think your bladder problem affects your life? * A lot Q3. ROLE: LIMITATIONS: Don your bladder problem affect A. your house hold tasks e.g. cleaning, * Alot shopping etc? B. your job or normal daily actis ities outside * A lot the home? Q4. PHYSICAL LIMITATIONS: Docs sour Madder problem affect A. your physical activities (e.g., going for walk. * Alot run. sports, gym. etc.)? B. your affect travel? * A lot Q5. SOCIAL LIMITATIONS: Does your Madder problem limit A. your social life? * Alot B. your limit your ability to see/visit friends? * Alot Q6. PERSONAL RELATIONSHIPS: Does your bladder problem affect A. your relationship with your partner? * A lot B. your sex life? * A lot C. your family life? * A lot Q7. EMOTIONS: Does your Madder problem make A. you feel depressed? * Very much B. you feel anxious and nervous? * Very much C. you feel bad about yourself? * Very much Q8. SLEEP/ ENERGY : Does your Madder problem A. affect your sleep? * A lot B. make you feel worn out and tired? * A lot Q9. SEVERITY MEASURES: A: Wear pads to keep dry? * All the time B: Be careful how much fluid you drink? * All the time C: Change your underclothes because they get wet * All the time D: Worry in case you smell * All the time Q10. SYMPTOM SEVERITY SCALE A. Frequency of urination * Severe B. Nocturia * Severe C. Urgency * Severe D. Urge Incontinence * Severe E. Stress Incontinence * Severe F. Nocturnal Enuresis * Severe G. Intercourse Incontinence * Severe H. Waterworks infection * Severe I. Bladder pain * Severe J. Postvoid dribble * Severe Q1. GENERAL HEALTH PERCEPTION: How would you describe your health at present? * Very poor Q2. INCONTINENCE IMPACT: How much do you think your bladder problem affects your life? Q3. ROLE: LIMITATIONS: Don your bladder problem affect A. your house hold tasks e.g. cleaning, shopping etc? B. your job or normal daily actis ities outside the home? Q4. PHYSICAL LIMITATIONS: Docs sour Madder problem affect A. your physical activities (e.g., going for walk. run. sports, gym. etc.)? B. your affect travel? Q5. SOCIAL LIMITATIONS: Does your Madder problem limit A. your social life? B. your limit your ability to see/visit friends? Q6. PERSONAL RELATIONSHIPS: Does your bladder problem affect A. your relationship with your partner? * Not applicable B. your sex life? * Not applicable C. your family life? * Not applicable Q7. EMOTIONS: Does your Madder problem make A. you feel depressed? B. you feel anxious and nervous? C. you feel bad about yourself? Q8. SLEEP/ ENERGY : Does your Madder problem A. affect your sleep? B. make you feel worn out and tired? Q9. SEVERITY MEASURES: A: Wear pads to keep dry? B: Be careful how much fluid you drink? C: Change your underclothes because they get wet D: Worry in case you smell Q10. SYMPTOM SEVERITY SCALE A. Frequency of urination B. Nocturia C. Urgency D. Urge Incontinence E. Stress Incontinence F. Nocturnal Enuresis G. Intercourse Incontinence H. Waterworks infection I. Bladder pain J. Postvoid dribble Calculation of Scores Q1 Very good=1, Good=2, Fair=3, Poor=4, Very poor=5 Q2 NM at all=1, A littlc=2, Moderately=3, A lot=4 Q3. Not at all=1, A little=2, Moderately=3, A lot=4 Q4 Not at all=1, A little=2, Moderately=3, A lot=4 Q5. Not at all=1, A little=2. Moderately=3. A lot=4 If Q6 C response is "Not Applicable" If Q6 C response is other than "Not Applicable" Q6. Not at all=1, A little=2, Moderately=3, A lot=4, Not applicable=0 If (6A+6B)[greater than or equal to] 2 lf (6A+6B)= 1 If (6A+6B) = 0 Q7. Not at all=1, A little-2, Moderately=3, Very much=4 Q8. Not at all=1, A little=2, Moderately=3, A lot=4 Q9. Never=1, Sometime=2, Often-3, All the time=4 Q10. None=0, Mild=1, Moderate=2, Severe=3 (for Responses A to J) Q1 Overall Score = ((Actual Score - 1)/4)x 100 Q2 Over all Score = ((Actual Score - 1 ) / 3) x 100 Q3 Overall Score = ((Actual Total Score - 2)/6)x 100 Q4 Overall Score = ((Actual Total Score - 2) / 6) x 100 Q5 Overall Score depends upon Q6C Score Q5 Overall Score = ((Actual Total Score - 2)/ 6) x 100 Q5 Overall Score = (Sum of scores to 5A, 5B. 6C)-3/9 X 100 Q6 Overall score is (Sum of scores to 6A, 6B)-2/6 X 100 Q6 Overall score is (Sum of scores to 6A, 6B)-1 /3 X 100 Q6 Score should be treated as missing value Q7 Overall Score (Sum of scores to 7A, 7B, 7C)-3 /9 X 100 Q8 Overall Score= ((Actual Total Score - 2)/6)x 100 Q9 Overall Score: (Actual Total Score =4) / 12 X 100 Q10 Overall Score is the total of responses to ten questions PART 1 SCORE = (Q1. OVERALL SCORE) + (Q2. OVERALL SCORE) PART 2 SCORE = OVERALL SCORE OF Q3 to Q9 PART 3 SCORE - OVERALL SCORE OF Q10 Layout Design: Dr Shripad Hebbar. MD, Department of Obstetrics Gynaecology. KMC Manipal, Manipal University
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Research Article|
|Author:||Pandey, Harshita; Hebbar, Shripad; Chawla, Arun|
|Publication:||International Journal of Medical Science and Public Health|
|Date:||Jul 1, 2015|
|Previous Article:||Health profile of DOTS-registered tuberculosis cases in a tertiary care hospital.|
|Next Article:||Mass drug administration coverage evaluation for elimination of lymphatic filariasis in Chhatarpur district of Madhya Pradesh.|